Cell Cycle Arrest Induced by the Vitamin D3 Analog EB1089 in NCI-H929 Myeloma Cells Is Associated with Induction of the Cyclin-Dependent Kinase Inhibitor p27

This publication has 33 references indexed in Scilit:

• Vitamin D3 analogs and their 24-Oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects
  Journal of Cellular Biochemistry, 1997
• Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
  Endocrinology, 1995
• Use of Vitamins A and D in Chemoprevention and Therapy of Cancer: Control of Nuclear Receptor Expression and Function
  Published by Springer Nature ,1995
• Effects of synthetic vitamin d analogues on breast cancer cell proliferation in vivo and in vitro
  Biochemical Pharmacology, 1992
• Topical calcipotriol treatment in advanced breast cancer
  The Lancet, 1991
• The Role of the Vitamin D Endocrine System in Health and Disease
  New England Journal of Medicine, 1989
• In vitro study of effects of 1,25 dihydroxyvitamin D3 on the morphology of human breast cancer cell line BT.20
  Differentiation, 1989
• 1,25(OH) ₂ ‐Vitamin D ₃ receptors: gene regulation and genetic circuitry
  The FASEB Journal, 1988
• 1,25-Dihydroxyvitamin D ₃ Receptors in Human Leukocytes
  Science, 1983
• 1,25-DIHYDROXYVITAMIN-D RECEPTOR IN BREAST CANCER CELLS
  The Lancet, 1979